Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

House Democrats

market access in Japan

Implementation of Cost-Effectiveness Analysis in Japan’s Health Technology Assessment Process

Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health technology assessment (HTA)...

Petauri Evidence

- PMLiVE

Ten participating drugmakers invited for further US Medicare drug price negotiations

ASPE revealed that the IRA is expected to save around 857,000 US women $1,000 or more in 2025

- PMLiVE

US government announces first ten drugs subject to Medicare pricing negotiations

The IRA programme is facing court challenges from leading drugmakers and industry groups

- PMLiVE

AstraZeneca latest to sue US government over Medicare drug price negotiation plan

The programme already faces court challenges from drugmakers and industry groups

- PMLiVE

Boehringer sues US government over Medicare drug price negotiation programme

The IRA allows Medicare to negotiate lower prices for selected medicines

- PMLiVE

Johnson & Johnson sues US government over Medicare drug price negotiation programme

The IRA allows Medicare to negotiate lower prices for a selected group of medicines

- PMLiVE

Merck sues US government over Medicare drug price negotiation programme

The drugmaker says the programme violates the First and Fifth Amendments to the US Constitution

- PMLiVE

The challenges of reimbursement and innovative pricing for cell and gene therapies

Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...

Avalere Health

- PMLiVE

US government announces first set of drugs subject to Medicare inflation rebates

The move could reduce out-of-pocket costs for Medicare beneficiaries by up to $390 per dose

- PMLiVE

US health department proposes three new models to help lower cost of drugs

One suggested model includes offering some essential generic drugs for $2 a month

- PMLiVE

Democrats in the US agree plan to curb drug prices

House Democrats have added a measure to curb prescription drug costs to President Biden’s $1.85tr social safety net plan

- PMLiVE

Lilly joins new Medicare scheme to reduce insulin prices

New model will cover seniors enrolled in Medicare Part D

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links